StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.60−0.05 (-7.66%)

Close on Nov 16, 2026Market cap $14.06MP/E –Yield –

Genenta Science S.p.A. cash

Cash and short-term investments held at the end of each period.

Genenta Science S.p.A.'s cash was €28.15M at Dec 31, 2025. For fiscal 2025 it was €28.15M, up 121.6% from the year before. The highest annual figure on record is €37.24M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€28.15M+121.6%
FY2024Dec 31, 2024€12.70M-32.4%
FY2023Dec 31, 2023€18.80M-36.9%
FY2022Dec 31, 2022€29.79M-20.0%
FY2021Dec 31, 2021€37.24M+140.8%
FY2020Dec 31, 2020€15.47M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025€28.15M+49.7%
Q2 FY2025Jun 30, 2025€17.70M-20.3%
Q4 FY2024Dec 31, 2024€12.70M-57.4%
Q2 FY2024Jun 30, 2024€16.91M-51.2%
Q4 FY2023Dec 31, 2023€18.80M-49.5%
Q2 FY2023Jun 30, 2023€22.21M+43.6%
Q4 FY2022Dec 31, 2022€29.79M–
Q2 FY2022Jun 30, 2022€34.67M–
Q4 FY2021Dec 31, 2021€37.24M–
Q4 FY2020Dec 31, 2020€15.47M–

More Genenta Science S.p.A. figures

See a number that looks wrong?